Xiyi Lu

1.4k total citations · 2 hit papers
29 papers, 1.0k citations indexed

About

Xiyi Lu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiyi Lu has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiyi Lu's work include RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (12 papers) and RNA Research and Splicing (8 papers). Xiyi Lu is often cited by papers focused on RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (12 papers) and RNA Research and Splicing (8 papers). Xiyi Lu collaborates with scholars based in China, United States and Finland. Xiyi Lu's co-authors include Erbao Zhang, Xuezhi He, Liang Han, Renhua Guo, Dandan Yin, Jun Su, Wei De, Wei Wang, Chongguo Zhang and Shidai Jin and has published in prestigious journals such as Advanced Materials, Nature Communications and Cancer Research.

In The Last Decade

Xiyi Lu

26 papers receiving 1.0k citations

Hit Papers

Cancer-associated fibroblasts promote EGFR-TKI resistance... 2025 2026 2025 2025 5 10 15
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1/glycolysis/H3K18la positive feedback loop
    2025 19 citations Chen Zhang, Jiali Xu et al. Oncogene profile →
  2. NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer
    2025 17 citations Xiyi Lu, Chang Zhang et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiyi Lu China 16 789 693 89 65 58 29 1.0k
Linda Pestano United States 14 694 0.9× 483 0.7× 87 1.0× 71 1.1× 30 0.5× 25 990
Monika M Gladka Netherlands 10 814 1.0× 454 0.7× 44 0.5× 56 0.9× 41 0.7× 22 1.0k
Erhu Fang China 16 926 1.2× 664 1.0× 77 0.9× 107 1.6× 38 0.7× 29 1.1k
Xiaocheng Zhou China 16 623 0.8× 488 0.7× 108 1.2× 197 3.0× 55 0.9× 29 927
Samir Ounzain Switzerland 15 1.1k 1.4× 878 1.3× 40 0.4× 32 0.5× 45 0.8× 26 1.3k
Wendong Bai China 14 528 0.7× 432 0.6× 36 0.4× 100 1.5× 28 0.5× 21 711
Samantha Cialfi Italy 19 527 0.7× 217 0.3× 116 1.3× 97 1.5× 52 0.9× 33 783

Countries citing papers authored by Xiyi Lu

Since Specialization
Citations

This map shows the geographic impact of Xiyi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiyi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiyi Lu more than expected).

Fields of papers citing papers by Xiyi Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiyi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiyi Lu. The network helps show where Xiyi Lu may publish in the future.

Co-authorship network of co-authors of Xiyi Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiyi Lu. A scholar is included among the top collaborators of Xiyi Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiyi Lu. Xiyi Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Xiaowen, Jiali Xu, Songren Shu, et al.. (2025). GLMP promotes EGFR-TKI resistance by activating autophagy and RhoA pathway in non-small cell lung cancer. npj Precision Oncology. 9(1). 391–391.
2.
Yin, Dandan, Xiyi Lu, Liang Xiao, et al.. (2025). STK11 genetic alterations in metastatic EGFR mutant lung cancer. Scientific Reports. 15(1). 5729–5729.
3.
Lu, Xiyi, Chang Zhang, Tianyu Qu, et al.. (2025). NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer. Molecular Cancer. 24(1). 79–79. 17 indexed citations breakdown →
4.
Lu, Xiyi, Qingwei Ji, Heng Pan, et al.. (2024). IL-23p19 deficiency reduces M1 macrophage polarization and improves stress-induced cardiac remodeling by alleviating macrophage ferroptosis in mice. Biochemical Pharmacology. 222. 116072–116072. 9 indexed citations
5.
Zhang, Yanghuan, Jiahua Liu, Yanduo Zhang, et al.. (2024). Curcumin analogue EF24 prevents alveolar epithelial cell senescence to ameliorate idiopathic pulmonary fibrosis via activation of PTEN. Phytomedicine. 133. 155882–155882. 14 indexed citations
6.
Lu, Xiyi, et al.. (2023). Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer. Oxidative Medicine and Cellular Longevity. 2023. 1–21. 14 indexed citations
7.
Wang, Jing, Xuezhi He, Qing Yao, et al.. (2023). LncRNA PTTG3P promotes tumorigenesis and metastasis of NSCLC by binding with ILF3 to maintain mRNA stability and form a positive feedback loop with E2F1. International Journal of Biological Sciences. 19(13). 4291–4310. 12 indexed citations
8.
Zhu, Qingqing, Chongguo Zhang, Tianyu Qu, et al.. (2022). MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc–Mediated Cell-Cycle Progression and Proliferation in Lung Cancer. Cancer Research. 82(23). 4340–4358. 65 indexed citations
9.
10.
He, Xuezhi, Jing Wang, Jin Chen, et al.. (2019). lncRNA UCA1 Predicts a Poor Prognosis and Regulates Cell Proliferation and Migration by Repressing p21 and SPRY1 Expression in GC. Molecular Therapy — Nucleic Acids. 18. 605–616. 33 indexed citations
11.
Liu, Xinyin, Xiyi Lu, Fuxi Zhen, et al.. (2019). LINC00665 Induces Acquired Resistance to Gefitinib through Recruiting EZH2 and Activating PI3K/AKT Pathway in NSCLC. Molecular Therapy — Nucleic Acids. 16. 155–161. 100 indexed citations
12.
13.
14.
Liu, Sheng, Sha Zhou, Xiyi Lu, Hongxing Wang, & J Li. (2018). Factors affecting localization and dispersion of alcohol in peripheral nerve block. Journal of Rehabilitation Medicine. 50(9). 837–842. 1 indexed citations
15.
Wu, Dan, Yetao Xu, Yanfen Zou, et al.. (2018). Long Noncoding RNA 00473 Is Involved in Preeclampsia by LSD1 Binding-Regulated TFPI2 Transcription in Trophoblast Cells. Molecular Therapy — Nucleic Acids. 12. 381–392. 33 indexed citations
16.
Li, Jun, Mingjie Lu, Jin Jiao, et al.. (2018). miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22. Cellular Physiology and Biochemistry. 50(1). 136–149. 40 indexed citations
17.
Zhang, Erbao, Xuezhi He, Chongguo Zhang, et al.. (2018). A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Genome biology. 19(1). 154–154. 221 indexed citations
18.
19.
Lu, Xiyi, Chenjun Huang, Xuezhi He, et al.. (2017). A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation. Cellular Physiology and Biochemistry. 42(5). 1857–1869. 48 indexed citations
20.
Feng, Jing, Yue Sun, Erbao Zhang, et al.. (2015). A novel long noncoding RNA IRAIN regulates cell proliferation in non small cell lung cancer.. PubMed Central. 8(10). 12268–75. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Pestano Breakdown of academic impact, for papers by Monika M Gladka Breakdown of academic impact, for papers by Erhu Fang Breakdown of academic impact, for papers by Xiaocheng Zhou Breakdown of academic impact, for papers by Samir Ounzain Breakdown of academic impact, for papers by Wendong Bai Breakdown of academic impact, for papers by Samantha Cialfi
Rankless by CCL
2026